Patients from two large cohorts, the African American Study of Kidney Disease and Hypertension (AASK) study, and the Chronic Renal Insufficiency Cohort (CRIC) study, were stratified by number of copies of high-risk APOL1 variants. This evidence concerns the gene APOL1 and chronic kidney disease.